EUVIMED · CrossrefZeitschrift
Thoracic Cancer
ISSN 1759-7706 · Wiley
Neueste Artikel
Issue Information
Disparities in Treatment Patterns for Advanced ALK ‐ and EGFR ‐Mutated Non‐Small Cell Lung Cancer Patients in Mexico
Prognostic Value of Early Dynamic Changes in Skeletal Muscle Index for Unresectable Lung Squamous Cell Carcinoma: A Prospective Landmark Analysis
Transformation to Small‐Cell Lung Carcinoma and Then to Sarcomatoid Carcinoma in an EGFR ‐Mutant Lung Adenocarcinoma Patient During Systemic Therapy: A Case Report
Correction to “Perioperative Outcomes of Robotic‐Assisted Versus Video‐Assisted Thoracoscopic Lobectomy: A Propensity Score Matched Analysis”
Integrating Machine Learning to Identify Prognostic Subtypes and the Cisplatin Resistance Gene RRM2 in Lung Adenocarcinoma
Preoperative Temporal Elevation of Cytokeratin 19 Fragment in Thymoma With Extensive Necrosis: A Case Report
Predicting for Malignancy in Congenital Lung Malformations: A Single‐Center Study of the “At Risk” Pediatric and Adult Population
Non‐Small Cell Lung Carcinoma With Bilayered Architecture and TP53 Alteration: A Diagnostic Pitfall and a Potential Distinct Entity
Protocol of a Real‐World Prospective Observational Study of Amivantamab Plus Chemotherapy in Patients With EGFR Exon 20 Insertion–Positive Non‐Small Cell Lung Cancer ( SPIRAL ‐ RACER20 Study)
Transesophageal Endoscopic Ultrasound With Bronchoscope‐Guided Fine‐Needle Aspiration for Tissue Diagnosis of Pleural Malignancy in a Patient With Respiratory Compromise
Issue Information
KRAS G12S Positive Non‐Small Cell Lung Cancer Mimicking KRAS G12C Positivity on the AmoyDx PCR Panel: A Case Report
Correction to “Clinical and Imaging Characteristics in the Diagnosis and Surgical Management of Nipple Discharge Without Clinically Palpable Masses: A Retrospective Cohort Study”
Efficacy and Safety of Immune Checkpoint Inhibitors for Lung Cancer Complicated by Interstitial Pneumonia: The CS ‐Lung 003 Study, Branch Number 28
Clinicopathological Features of DLL3 Expression and T‐Cell Infiltration in LCNEC : Insights From Pathology and Clinical Response to Tarlatamab
Nodule Dye‐Localization Using Interventional Fluoroscopy for Image‐Guided Sublobar Lung Resection
Efficacy and Safety of Trilaciclib for the Prevention of Chemotherapy‐Induced Myelosuppression in Patients With Solid Tumors: A Systematic Review and Meta‐Analysis
Exhaled Breath Analysis for Lung Cancer Detection: From VOCs Signatures to EBC ‐Based Liquid Biopsy and Clinical Translation
SRC Activation Drives Acquired Pemetrexed Resistance in Non‐Small Cell Lung Cancer and Is Targetable by Dasatinib
Perioperative Antifibrotic Treatment and Early Postoperative Outcomes in Patients With Idiopathic Pulmonary Fibrosis Undergoing Lung Cancer Surgery: A Systematic Review and Meta‐Analysis
Matrine Suppresses Lung Cancer Progression via Dual Inhibition of CHEK1 ‐Mediated DNA Damage Repair and PI3K / AKT Survival Signaling
Synergistic Antitumor Efficacy of Radiofrequency Ablation Combined With TROP2 ‐ CAR ‐T Cells in a Xenograft Mouse Model of Lung Adenocarcinoma
Kirsten Rat Sarcoma Viral Oncogene Homolog ( KRAS ) Mutation Testing Trends, Prevalence, and Outcomes in Metastatic, Non‐Squamous Non‐Small Cell Lung Cancer (Non‐ SQ NSCLC ) Patients in Queensland, Australia From 2014–2023
Efficacy of Osimertinib in Patients With Postoperative Recurrent Non–Small‐Cell Lung Cancer Harboring Sensitizing EGFR Mutations
Blood Based Biomarkers for Predicting Treatment Response to Immune Checkpoint Inhibitors After EGFR ‐ TKI Resistance in Non‐Small Cell Lung Cancer
Impact of Long‐Term Structured Exercise on Body Composition in an NTRK Fusion‐Positive NSCLC Patient Treated With Entrectinib
Hepatobiliary Adverse Events Linked to Immune Checkpoint Inhibitors: A Real‐World Pharmacovigilance Analysis Using FAERS Data
Discovery the Mechanism of Qingdi Mixture for Radiation‐Induced Lung Injury Based on Network Pharmacology, Clinical Retrospective Analysis and Experimental Validation
The Progression Patterns and Subsequent Treatments of First‐Line Immunotherapy in Advanced Non‐Small Cell Lung Cancer: A Retrospective Cohort Study
EUVIMED